Shandong Teamgene Technology Co., Ltd. Class A

Shandong Teamgene Technology Co., Ltd. Class A

SSSE:603151
23.35
CNY
+0.93
(+4.15%)
-0.31EPS
677.87P/E
3.05BMarket Cap
Apr 27Next Earn
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
9.21
5.98
14.48
16.15
12.47
9.8
15.13
33.62
34.64
Basic EPS, GAAP
0.35
0.32
0.94
1.16
0.91
0.5
0.3
0.65
0.03
Free Cash Flow per Basic Share
-0.02
0.45
1.23
0.27
-0.85
-1.87
-1.33
-4.45
- -
Dividend per Share
0.01
0.18
0.39
0.31
0.01
0.5
0.24
0.34
0.42
Book Value per Share
1.2
1.39
2.51
3.37
7.31
7.31
7.42
8.05
8.01
Tangible Book Value per Share
1.05
1.25
2.27
2.99
6.99
6.91
6.9
7.54
7.5
Basic Weighted Avg Shares
126
168
119
126
133
168
168
170
171
Sales/Revenue/Turnover
1,160
1,005
1,724
2,035
1,658
1,647
2,542
5,699
5,939
Operating Margin (%)
4.92
6.42
7.35
7.6
7.7
6.15
3.8
4.34
1.82
Depreciation Expense
7
8
8
12
15
29
51
74
- -
Net Income, GAAP
44
53
112
146
120
84
50
111
4
Effective Tax Rate (%)
18.86
9.72
11.53
14.67
13.02
16.11
18.56
23.73
- -
Profit Margin (%)
3.76
5.32
6.49
7.17
7.26
5.09
1.97
1.94
0.08
Working Capital
54
86
201
225
851
588
483
614
740
LT Debt
- -
- -
4
3
3
11
12
141
241
Total Equity
153
178
319
427
1,230
1,237
1,281
1,517
1,465
Return on Invested Capital (%)
- -
29.22
42.26
33.14
12.76
6.42
3.81
5.06
- -
Return on Capital (%)
- -
28.52
41.75
36.74
14.34
6.53
3.82
6.75
- -
Return on Common Equity (%)
- -
32.69
45.47
39.32
14.57
6.83
4.05
8.45
0.33

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
1,154
1,306
1,188
LT Borrowings
106
103
151
LT Finance Leases
96
93
90
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
171
171
172
Market Capitalization
2,801
1,882
3,054

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
2,500
2,741
2,796
Cash, Cash Equivalents & STI
550
722
721
Accounts Receivable, Net
1,246
1,287
1,298
Inventories
531
578
615
Total Current Liabilities
1,843
2,145
2,056
Payables & Accruals
- -
- -
- -
ST Debt
1,154
1,306
1,188
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
48.89%
18.43%
Free Cash Flow
- -
-24.57%
236.43%
Net Income, GAAP
- -
12.68%
121.12%
Sales/Revenue/Turnover
- -
35.49%
124.24%
Total Cash Common Dividend
- -
1,218.97%
44.99%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
412
483
729
917
2,542
2025
1,076
1,317
- -
1,551
5,699
2026
1,445
1,231
1,712
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.12
0.02
0.11
0.04
0.3
2025
0.17
0.22
- -
0.03
0.65
2026
0.02
-0.03
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.01
0.22
0.01
0.24
2025
0.01
0.04
- -
0.11
0.34
2026
0.05
0.09
0.17
- -
- -

Company Description

CEO
Hong Chao Zhang
Full Time Employees
1,348
Sector
Technology services
Industry
Information technology services
Address
Zibo China
IPO Date
Oct 19, 2022
Business
Shandong Teamgene Technology Co., Ltd. Class A engages in the research, development, production, and distribution of animal feeds and livestock nutritional solutions in the People's Republic of China. The company operates through specialized business segments focused on animal nutrition, livestock healthcare, and breeding management technologies. Its product portfolio comprises swine feeds, including pig compound feeds designed for complete nutritional support across various life stages; pig concentrate feeds formulated with proteins, minerals, and vitamins for on-farm mixing; and high-technology pig premix feeds containing concentrated vitamins, trace elements, and amino acids, featuring proprietary product lines such as the Bangji series; poultry nutrition products, including premixes and specialized feeds for laying hens; ruminant feeds tailored for meat cattle and sheep; and nutritional feed additives. The company also offers veterinary pharmaceuticals and biological products, alongside technical services encompassing precision nutrition formulation, breeding management consulting, animal disease prevention, and ecological farming solutions for commercial pig farms, livestock enterprises, and agricultural cooperatives. Shandong Teamgene Technology operates manufacturing bases and supply networks across Shandong Province, including Zibo, Qingdao, Yantai, Linyi, and Binzhou, as well as production facilities in Jilin, Sichuan, Liaoning, Yunnan, and Shanxi provinces. In recent developments, the company has advanced strategic initiatives to expand its value chain toward vertically integrated feed processing and swine breeding operations, having pursued major asset restructuring and acquisition transactions involving commercial hog farming assets and livestock consulting entities such as Pipestone Livestock Technology Consulting (Shanghai) Co., Ltd., while continually executing capacity expansion programs across its regional production facilities and advancing nutritional research through its academician workstation, Nutritional Engineering Technology Research Center, and Animal Life Research Institute. Founded in April 2007, Shandong Teamgene Technology Co., Ltd. is headquartered in Zibo, China.